Oppenheimer & Co. Inc. Has $6.15 Million Stock Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Oppenheimer & Co. Inc. cut its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 14.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,352 shares of the biotechnology company’s stock after selling 1,759 shares during the period. Oppenheimer & Co. Inc.’s holdings in Axon Enterprise were worth $6,152,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in AXON. Prestige Wealth Management Group LLC raised its holdings in Axon Enterprise by 115.8% in the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock valued at $33,000 after acquiring an additional 44 shares in the last quarter. New Wave Wealth Advisors LLC acquired a new position in shares of Axon Enterprise during the 4th quarter worth $40,000. Brooklyn Investment Group acquired a new position in shares of Axon Enterprise during the 3rd quarter worth $41,000. Y.D. More Investments Ltd acquired a new position in shares of Axon Enterprise during the 4th quarter worth $45,000. Finally, Planning Capital Management Corp raised its holdings in shares of Axon Enterprise by 83.3% during the 3rd quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after buying an additional 55 shares in the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Axon Enterprise

In related news, Director Michael Garnreiter sold 1,000 shares of the company’s stock in a transaction dated Monday, December 16th. The stock was sold at an average price of $639.69, for a total transaction of $639,690.00. Following the sale, the director now owns 24,259 shares in the company, valued at $15,518,239.71. This represents a 3.96 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the company’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the sale, the director now owns 6,929 shares in the company, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 8,711 shares of company stock worth $5,631,561. Insiders own 6.10% of the company’s stock.

Axon Enterprise Trading Up 0.6 %

NASDAQ AXON opened at $528.45 on Friday. The business’s 50-day moving average price is $609.55 and its two-hundred day moving average price is $523.20. Axon Enterprise, Inc. has a 12 month low of $273.52 and a 12 month high of $715.99. The firm has a market capitalization of $40.30 billion, a PE ratio of 136.55, a price-to-earnings-growth ratio of 5.17 and a beta of 1.05. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32.

Analysts Set New Price Targets

A number of equities analysts have recently commented on AXON shares. Barclays set a $726.00 price target on Axon Enterprise and gave the stock an “overweight” rating in a report on Thursday. Northland Securities boosted their price target on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a report on Monday, November 11th. Needham & Company LLC reissued a “buy” rating and set a $600.00 price target on shares of Axon Enterprise in a report on Wednesday. Northcoast Research cut Axon Enterprise from a “buy” rating to a “neutral” rating in a report on Wednesday, February 19th. Finally, The Goldman Sachs Group upped their target price on Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a report on Monday, January 27th. Three equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat, Axon Enterprise has a consensus rating of “Moderate Buy” and a consensus price target of $587.38.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.